As a neonatologist working in Western New York’s most advanced neonatal intensive care unit (NICU) at the John R. Oishei Children’s Hospital, I care for critically ill preterm and term newborn infants. My expertise includes caring for extremely premature infants and the associated comorbidities that often come with premature birth, as well as hypoxic respiratory failure, hypoxic ischemic encephalopathy, and pulmonary hypertension.
My research focuses on neonatal resuscitation and understanding the physiology of pulmonary transition at birth in asphyxia and to compare the effectiveness of various techniques (femoral occlusion), medications (vasopressin and epinephrine), and devices (laryngeal mask airway) during resuscitation. The results from these studies will have a pronounced clinical impact globally by improving resuscitation guidelines that hasten recovery and reduce death and neurological disability following birth asphyxia.
I also conduct clinical research, in our mother–baby unit, on the use of oral dextrose gel in the treatment of neonatal hypoglycemia. The results thus far have shown a reduction in NICU admissions for neonatal hypoglycemia, which prevents separating mothers from their babies. I am working towards increasing the rates of skin-to-skin care (kangaroo mother care) in our unit. To accomplish this in very sick and premature infants who cannot be held, I am developing a kangaroo care mattress in collaboration with our biomedical engineering team.
As a neonatologist working in Western New York’s most advanced neonatal intensive care unit (NICU) at the John R. Oishei Children’s Hospital, I care for critically ill preterm and term newborn infants. My expertise includes caring for extremely premature infants and the associated comorbidities that often come with premature birth, as well as hypoxic respiratory failure, hypoxic ischemic encephalopathy, and pulmonary hypertension.
My research focuses on neonatal resuscitation and understanding the physiology of pulmonary transition at birth in asphyxia and to compare the effectiveness of various techniques (femoral occlusion), medications (vasopressin and epinephrine), and devices (laryngeal mask airway) during resuscitation. The results from these studies will have a pronounced clinical impact globally by improving resuscitation guidelines that hasten recovery and reduce death and neurological disability following birth asphyxia.
I also conduct clinical research, in our mother–baby unit, on the use of oral dextrose gel in the treatment of neonatal hypoglycemia. The results thus far have shown a reduction in NICU admissions for neonatal hypoglycemia, which prevents separating mothers from their babies. I am working towards increasing the rates of skin-to-skin care (kangaroo mother care) in our unit. To accomplish this in very sick and premature infants who cannot be held, I am developing a kangaroo care mattress in collaboration with our biomedical engineering team.